In situations where the FOXO4 protein is bound to p53, there is a tentative observation that p53 is prevented from binding to DNA, inhibiting the process of apoptosis and allowing cells to avoid programmed death
Kwon HJ, Lee KL, Lee SI, et al
Multiple rodent studies have demonstrated that BPC 157 administration both locally and systemically reduces markers of gastric damage, accelerates mucosal healing in ulcer models, and appears to counteract the damage caused by NSAIDs and corticosteroids
The FDA has stated that BPC-157 may pose an immunogenicity risk, and due to a lack of adequate safety-related information, would consider taking regulatory action against 503A compounders that compound drug products that include BPC-157 (U.S
J Hepatol 12:162169
Glow Peptide is a nickname for an injectable peptide stack that includes GHK-Cu (copper peptides), BPC-157, and TB-500, designed to rejuvenate the skin for a glow-up